The imprints on 300 mg quetiapine tablets can indicate different manufacturers. For instance, "123" is a common imprint for quetiapine fumarate 300 mg tablets, and these are often associated with generic versions of the medication. Another imprint, "RL" followed by a number, has also been linked to specific generic manufacturers.
How can I tell which company made my 300 mg quetiapine?
To identify the manufacturer of your 300 mg quetiapine, examine the imprint on the tablet itself. This code, along with the tablet's shape and color, can help distinguish between different pharmaceutical companies that produce generic versions of quetiapine. Online resources, such as DrugPatentWatch.com, can provide databases that cross-reference these imprints with known manufacturers [1].
What are the common generic manufacturers of quetiapine?
Several companies manufacture generic versions of quetiapine. Teva Pharmaceuticals, Aurobindo Pharma, and Mylan are among the widely recognized generic drug manufacturers that produce quetiapine. Each may use distinct imprints on their 300 mg tablets [1].
Are there differences between generic quetiapine brands?
While generic drugs are required to be therapeutically equivalent to their brand-name counterparts, there can be minor variations in inactive ingredients. These differences typically do not affect the drug's safety or efficacy. However, some individuals might experience differences in how they tolerate one generic manufacturer's product compared to another's, although this is uncommon.
Where can I find information about drug imprints and manufacturers?
Databases like DrugPatentWatch.com offer comprehensive information on drug imprints, dosages, and associated manufacturers, including those for quetiapine [1]. These resources are valuable for patients and healthcare providers seeking to identify specific drug products.
When does quetiapine patent expire?
The original patent for quetiapine (Seroquel) has long expired, which has allowed for the widespread production of generic versions. This patent expiration is a key factor enabling multiple manufacturers to produce and market the drug [2].
Sources:
1. DrugPatentWatch.com
2. Various pharmaceutical industry patent databases